Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction of resistance to azole drugs in Trypanosoma cruzi.

Antimicrobial agents and chemotherapy - 1 Dec 1998

Buckner F S, Wilson A J, White T C, Van Voorhis W C

Abstract excerpt

Trypanosoma cruzi is the protozoan parasite that causes Chagas' disease, a frequently fatal illness affecting the heart and gastrointestinal systems. An estimated 16 million to 18 million people in Latin America and 50,000 to 100,000 people in the United States are infected with this pathogen. Treatment options for T. cruzi infections are suboptimal due to the toxicities and limited effectiveness of the available...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fluconazole
Share to Mice
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mice, Inbred BALB C

Share to Drug Resistance

Share to Trypanosoma cruzi

Source

Open in PubMed Open full text

Identifiers

PMID: 9835521
DOI: 10.1128/AAC.42.12.3245
PMCID: PMC106029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induction of resistance to azole drugs in Trypanosoma cruzi.PMID 9835521Read ↗

Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity.Semantic proximity Read ↗

In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.Semantic proximity Read ↗

Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes.Semantic proximity Read ↗

In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.Semantic proximity Read ↗

Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational ModelsSemantic proximity Read ↗

Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin.Semantic proximity Read ↗

Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population.Semantic proximity Read ↗

Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with VirulenceSemantic proximity Read ↗

Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concertSemantic proximity Read ↗

Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.Semantic proximity Read ↗

Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.Semantic proximity Read ↗

Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.